✦ LIBER ✦

Prostatic specific antigen in prostatic cancer and benign hyperplasia

✍ Scribed by N. E. Kushlinskii; N. V. Lyubimova; L. M. Gorilovskii

Publisher: Springer US
Year: 1997
Tongue: English
Weight: 411 KB
Volume: 124
Category: Article
ISSN: 0007-4888
DOI: 10.1007/bf02447000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tissue concentrations of prostate-specif

Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia

✍ Thomas G. Pretlow; Theresa P. Pretlow; Bin Yang; Charlotte S. Kaetzel; Carrie M. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 775 KB

## Abstract Prostate‐specific antigen (PSA), as measured in peripheral blood, is currently the most widely used marker for the assessment of tumor burden in the longitudinal study of patients with carcinoma of the prostate (PCA). Studies from other laboratories have led to the conclusion that a giv

Impact of age, benign prostatic hyperpla

Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level

✍ Rinaa S. Punglia; Anthony V. D'Amico; William J. Catalona; Kimberly A. Roehl; Ka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

## Abstract ## BACKGROUND The distribution of prostate‐specific antigen (PSA) values for men with or without prostate carcinoma are confounded because of verification bias. Correcting for verification bias, the means and variances of PSA values were estimated in specific clinical scenarios. ## ME

Increased discrimination between benign

Increased discrimination between benign prostatic hyperplasia and prostate cancer with equimolar total prostate specific antigen measurement

✍ R. Onur; N. Ilhan; I. Orhan; N. Ilhan 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 195 KB

Two-dimensional electrophoresis of prost

Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia

✍ Jean-Philippe Charrier; Carole Tournel; Sandrine Michel; Pascal Dalbon; Michel J 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Two-dimensional electrophoresis of prostatespecific antigen in sera of men with prostate cancer or benign prostate hyperplasia Prostate-specific antigen (PSA), the main marker for prostate cancer (PCa), is released from the prostate into the blood stream at nanogram level and may increase in PCa and

Increased differentiation between prosta

Increased differentiation between prostate cancer and benign prostatic hyperplasia through measurement of the percentage of free prostate-specific antigen

✍ J. M. Wolff; H. Borchers; W. Boeckmann; F. K. Habib; G. Jakse 📂 Article 📅 1997 🏛 Springer 🌐 German ⚖ 207 KB

Leptin in relation to prostate cancer an

Leptin in relation to prostate cancer and benign prostatic hyperplasia

✍ Pagona Lagiou; Lisa B. Signorello; Dimitrios Trichopoulos; Anastasia Tzonou; Ant 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 44 KB 👁 2 views

The aim of our study was to determine whether leptin, a hormone implicated in both energy-balance and reproductive function, is involved in the etiology of prostate cancer or benign prostatic hyperplasia (BPH). We compared the serum leptin levels of 43 cases of incident prostate cancer, 41 patients